United StatesFasenra (benralizumab) Injection, 30 mg/mL, one single‑dose pre-filled syringe (NDC 0310-1730-30), lot YJ0152, expiry 01/31/2028, manufactured by AstraZeneca AB and distributed by AstraZeneca Pharmaceuticals, is being recalled in the United States. The recall, covering 916 pre-filled syringes sold nationwide, was initiated because of a lack of assurance of sterility.
What's being recalled
Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB, Sweden, Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. NDC 0310-1730-30
Recalling firm: Astrazeneca Pharmaceuticals, Gaithersburg, MD, United States.
How to identify it
Lot YJ0152, Expiry: 01/31/2028.
The hazard
Lack of Assurance of Sterility:
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
Nationwide in the U.S
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)